Medicare reviewing over Dendreon cancer vaccine
The U.S. Medicare program said on Wednesday it was evaluating data on Dendreon Corp’s prostate cancer therapy to decide whether to cover the product for seniors nationwide.
The shares of Dendreon Corp. plummeted by 23% and became $25 after the news came and closed in on $32.33 on Nasdaq.
The Centers for Medicare & Medicaid Services (CMS) [...]
Teesside Cancer support by Macmillan
Who we are
The Macmillan Cancer Information and Support Service have been developed as a joint venture between Macmillan Cancer Support, The George Hardwick Foundation and the North Tees and Hartlepool NHS Foundation Trust.
We ensure people affected by, or concerned about, cancer have access to good quality, comprehensive and appropriate information and support. The service is [...]
